BIODIAL spol. s.r.o.
- Address
- Pod Lachovcom 1727/55, 020 01 Púchov, Slovakia
BIODIAL spol. s.r.o. - Chronic Kidney Disease Research Center
BIODIAL spol. s.r.o. is a specialized clinical research facility dedicated to advancing the understanding and treatment of chronic kidney disease (CKD) and associated cardiovascular complications. The center demonstrates particular expertise in evaluating novel therapeutic combinations and investigational agents targeting kidney function preservation, proteinuria reduction, and cardiovascular risk management in patients with renal disease.
- Chronic kidney disease progression studies with novel drug combinations including baxdrostat and zibotentan with dapagliflozin
- End-stage kidney disease (ESKD) and cardiovascular outcomes research in dialysis populations
- Proteinuria reduction trials and renal function preservation studies
- Hypertension management in patients with chronic kidney disease
The center's research portfolio emphasizes critical clinical endpoints including estimated glomerular filtration rate (eGFR) monitoring, urine albumin-creatinine ratio (UACR) assessment, and composite cardiovascular-renal outcomes. BIODIAL conducts comprehensive dose-finding and Phase III efficacy studies, with particular focus on patients requiring maintenance dialysis and those with high proteinuria, contributing valuable data to the development of next-generation therapies for preserving kidney function and preventing cardiovascular mortality in CKD populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1AstraZeneca AB1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in BIODIAL spol. s.r.o.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects with End Stage Kidney Disease Undergoing Dialysis | CSL Behring LLC | Phase IV | Recruiting | Jul 2023 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 3 | Unknown | 2024-04-04 | 2025-05-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.